Skip to main content
MorphoSys AG logo

MorphoSys AG — Investor Relations & Filings

Ticker · MOR ISIN · DE000A3H2XW6 LEI · 529900493806K77LRE72 F Manufacturing
Open in API
Filings indexed 1,418 across all filing types
Latest filing 2020-10-13 Capital/Financing Update
Country DE Germany
Listing F MOR

About MorphoSys AG

https://www.morphosys.com/

MorphoSys AG is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines, primarily for cancer patients. The company specializes in creating therapeutic monoclonal antibodies, utilizing its long-standing expertise and proprietary technology platforms to generate fully human antibodies. Its research and development efforts are concentrated on building a pipeline of novel treatments to address significant unmet medical needs in oncology. In February 2024, Novartis entered into an agreement to acquire MorphoSys, aiming to integrate its antibody technologies and oncology pipeline.

Recent filings

Filing Released Lang Actions
MorphoSys AG Successfully Places EUR 325 Million Convertible Bonds
Capital/Financing Update Classification · 1% confidence The document is a news release dated October 13, 2020, announcing that MorphoSys AG successfully placed EUR 325 Million in unsubordinated, unsecured convertible bonds. This action directly relates to the company raising capital and changing its capital structure through the issuance of debt convertible into equity. This aligns perfectly with the definition of 'Capital/Financing Update' (Code: CAP). It is not an Earnings Release (ER), Interim Report (IR), or Annual Report (10-K), as it focuses solely on the financing transaction details.
2020-10-13 English
Ad hoc: MorphoSys AG Launches an Offering of approx. EUR 325 Million Convertible Bonds
Capital/Financing Update Classification · 1% confidence The document is an 'Ad hoc release' dated October 13, 2020, announcing that MorphoSys AG is launching an offering of approximately EUR 325 Million Convertible Bonds. This action directly relates to the company raising capital or changing its financing structure. Based on the definitions, this clearly falls under 'Capital/Financing Update' (Code: CAP). It is not an Earnings Release (ER), Interim Report (IR), or a general Regulatory Filing (RNS), as it pertains to a specific financing event.
2020-10-13 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled 'Voting Rights Announcements' and explicitly states 'Notification of Major Holdings' under German Securities Trading Act (WpHG) regulations. It details changes in voting rights percentages held by BlackRock, Inc. (crossing thresholds from 4.18% to 4.37% direct voting rights, and total 5.16%). This content directly corresponds to notifications required when a shareholder's stake crosses specific ownership thresholds, which falls under the category of Major Shareholding Notification (MRQ) or, given the regulatory context and content, potentially a specific type of regulatory filing. Since the core content is the notification of a change in major shareholding percentage by an external entity (BlackRock), the most precise fit among the provided codes is 'Major Shareholding Notification' (MRQ). It is not an Earnings Release (ER), Interim Report (IR), or Annual Report (10-K).
2020-10-09 English
DGAP-DD: MorphoSys AG english
Director's Dealing Classification · 1% confidence The document is explicitly titled 'Directors’ Dealings' and contains a section labeled 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. It details the name of an executive (Jens Holstein), his position, and a comprehensive list of share transactions (Disposal of shares) including prices, volumes, and dates. This content directly matches the definition for Director's Dealing.
2020-10-06 English
DGAP-DD: MorphoSys AG english
Director's Dealing Classification · 1% confidence The document is explicitly titled 'Directors’ Dealings' and contains a section header 'DGAP-DD: MorphoSys AG english' followed by 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. This content directly corresponds to the definition of Director's Dealing reports, which track insider trades by management. The corresponding code is DIRS.
2020-10-06 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed information regarding the 'Notification of Major Holdings' by BlackRock, Inc. in MorphoSys AG, referencing specific German securities law articles (WpHG, Sec. 40, 33, 34, 38). This type of filing, which reports changes in significant share ownership thresholds, directly corresponds to the definition of a Major Shareholding Notification. Although the header mentions 'Voting Rights Announcements', the content structure and purpose align perfectly with the 'Major Shareholding Notification' category (MRQ) rather than 'Declaration of Voting Results & Voting Rights Announcements' (DVA), which typically reports the outcome of a vote already taken. Since the core content is about crossing ownership thresholds, MRQ is the most precise fit.
2020-10-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.